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Introduction: Functional assessment of arterial load by dynamic arterial elastance (Eadyn), defined as the ratio
between pulse pressure variation (PPV) and stroke volume variation (SVV), has recently been shown to predict the
arterial pressure response to volume expansion (VE) in hypotensive, preload-dependent patients. However, because
both SVV and PPV were obtained from pulse pressure analysis, a mathematical coupling factor could not be
excluded. We therefore designed this study to confirm whether Eadyn, obtained from two independent signals,
allows the prediction of arterial pressure response to VE in fluid-responsive patients.
Methods: We analyzed the response of arterial pressure to an intravenous infusion of 500 ml of normal saline in 53
mechanically ventilated patients with acute circulatory failure and preserved preload dependence. Eadyn was
calculated as the simultaneous ratio between PPV (obtained from an arterial line) and SVV (obtained by esophageal
Doppler imaging). A total of 80 fluid challenges were performed (median, 1.5 per patient; interquartile range, 1 to
2). Patients were classified according to the increase in mean arterial pressure (MAP) after fluid administration in
pressure responders (≥10%) and non-responders.
Results: Thirty-three fluid challenges (41.2%) significantly increased MAP. At baseline, Eadyn was higher in pressure
responders (1.04 ± 0.28 versus 0.60 ± 0.14; P <0.0001). Preinfusion Eadyn was related to changes in MAP after fluid
administration (R2 = 0.60; P <0.0001). At baseline, Eadyn predicted the arterial pressure increase to volume expansion
(area under the receiver operating characteristic curve, 0.94; 95% confidence interval (CI): 0.86 to 0.98; P <0.0001). A
preinfusion Eadyn value ≥0.73 (gray zone: 0.72 to 0.88) discriminated pressure responder patients with a sensitivity of
90.9% (95% CI: 75.6 to 98.1%) and a specificity of 91.5% (95% CI: 79.6 to 97.6%).
Conclusions: Functional assessment of arterial load by Eadyn, obtained from two independent signals, enabled the
prediction of arterial pressure response to fluid administration in mechanically ventilated, preload-dependent
patients with acute circulatory failure.Introduction
Correction of arterial hypotension is essential for adequate
cellular metabolism [1,2]. Although there is no single
mean arterial pressure (MAP) value that guarantees a
global perfusion pressure [3], maintaining MAP above a
minimum level has been recommended in order to* Correspondence: ignaciomonge@gmail.com
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unless otherwise stated.prevent further tissue hypoperfusion and organ dysfunc-
tion [4-6]. In this regard, fluid administration is still con-
sidered the first-choice therapy to restore arterial pressure
in most hemodynamic resuscitation protocols [4-6]. How-
ever, because arterial pressure results from the interaction
between the arterial system and the blood ejected by the
heart [7], the response of blood pressure to fluids con-
tinues to be a challenge [8-12]. Therefore, even if a patient
is able to increase cardiac output (CO) with fluids, the ar-
terial pressure response cannot easily be predicted [13].
So, in order to determine whether fluid administration will
improve arterial pressure, it is necessary to evaluate nottd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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load [14]—that is, the net force imposed on left ventricu-
lar ejection that defines, along with left ventricular stroke
volume (SV), the arterial pressure [15].
In a previous study, we found that dynamic arterial elas-
tance (Eadyn), defined as the pulse pressure variation (PPV)
to stroke volume variation (SVV) ratio, could predict the
arterial pressure increase after volume expansion (VE) in
hypotensive, preload-dependent patients [13]. However, be-
cause both SVV and PPV were obtained from the pulse
pressure analysis, mathematical coupling could not be
rejected as a reason for the findings; thus, a validation study
was necessary before Eadyn could be recommended for clin-
ical decision-making [16].
The aim of this study was to confirm the usefulness of
Eadyn as a predictor of the arterial pressure response to
fluid administration by simultaneously measuring SVV
and PPV from two independent signals.Methods
This observational study was conducted in the Intensive
Care Unit of the Hospital SAS de Jerez during a 1-year
period (from July 2012 to July 2013). Approval from our
Institutional Research Ethics Committee (Cómite de
Ética de la Investigación de Jerez-Sierra-Costa Noroeste,
Acta 3, April 2012) was obtained. Informed consent was
deemed unnecessary because the study protocol and the
monitoring procedures were considered to be part of
routine clinical care.Patients
We prospectively included all patients equipped with an
indwelling arterial catheter and evaluated by esophageal
Doppler monitoring who were receiving a fluid challenge
for the presence of clinical signs of acute circulatory fail-
ure, including hypotension (defined as a MAP ≤65 mmHg
or a systolic arterial pressure (SAP) ≤90 mmHg); require-
ment for vasopressor drugs, presence of lactic acidosis,
urine output ≤0.5 ml∙kg−1∙hr−1 during at least 2 hours,
heart rate >100 beats/min and/or the presence of skin
mottling. Preload dependency was assessed according to
our institutional protocol for hemodynamic resuscitation
and defined as a CO increase ≥10% after a 2-minute leg-
raising maneuver [17]. In all cases, the final decision to
start or continue fluid administration was made by the
treating physician.
Patients were under controlled mechanical ventilation
with no spontaneous respiratory efforts, as assessed by
visual inspection of the airway pressure curve. Patients
with unstable cardiac rhythm were excluded, although
this condition did not affect the decision to administer
fluids.Hemodynamic monitoring
Patients were monitored with an esophageal Doppler
monitoring system (CardioQ-Combi™; Deltex Medical,
Chichester, UK). This system combines a standard Dop-
pler monitor with arterial pressure analysis capability. The
probe was inserted into the esophagus, preferably using
the nasal route, and advanced until the maximal peak vel-
ocity of the aortic blood flow was reached. The gain set-
ting was adjusted to obtain the optimum outline of the
Doppler waveform. In order to reduce signal noise from
heart valves and wall thump artifact, a built-in filter func-
tion was activated in some patients and kept unchanged
throughout the study.
An arterial pressure transducer (TruWave; Edwards
Lifesciences, Irvine, CA, USA) was zeroed to atmospheric
pressure, and optimal damping of the arterial waveform
was carefully checked by fast-flushing the line. The arterial
pressure signal was transferred from the patient’s bedside
monitor to the Doppler system using a serial cable and
automatically synchronized with the aortic blood flow
waveform for analysis (Additional file 1: Figure S1).
Arterial load assessment
Our arterial load assessment was grounded on a basic
physiological framework based on a two-element Wind-
kessel model of arterial circulation with static and dy-
namic components. The static component represents a
unique pressure–volume (P–V) relationship and can be
described by a resistive element or the systemic vascular
resistance (SVR =MAP/CO*80) and a pulsatile element or
the net arterial compliance (C = SV/arterial pulse pres-
sure) [18]. This distinction is a product of the oscillatory
nature of the arterial flow and the mechanical properties
of the arterial system [7]. The effective arterial elastance
(Ea = 0.9*SAP/SV) is considered an integrative variable of
arterial load that incorporates both steady and pulsatile
elements [15,19,20]. Dynamic assessment of arterial load
was performed by calculating Eadyn, which we defined as
the ratio between PPV and SVV during a respiratory cycle.
Rather than being a steady-state variable, Eadyn depicts the
slope of the P–V relationship and provides a functional as-
sessment of arterial load [21]. PPV obtained from the ar-
terial line and SVV from the aortic blood flow were
simultaneously calculated by using the Doppler monitor
software with the standard formulae [22] and averaged
over three respiratory cycles (Figure 1). In order to do so,
respiratory rate was manually introduced on the Doppler
monitor.
Study protocol
All hemodynamic variables were measured prior to and
just after VE, consisting of 500 ml of normal saline
given within 30 minutes. No changes in ventilatory
settings or vasoactive drugs were made during volume
Figure 1 An illustrative example of the arterial pressure and aortic blood flow recordings is shown. Both signals are integrated into the
esophageal Doppler system for analysis: the arterial pressure waveform from the patient’s bedside monitor and the aortic blood flow from the
Doppler probe. Dynamic arterial elastance was calculated as the ratio between pulse pressure variation and stroke volume variation. All variables
are automatically calculated by the Doppler monitor, which combines the arterial pressure analysis with the usual aortic blood
flow measurements.
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study. All hemodynamic variables were automatically re-
corded every 10 seconds and averaged over 1 minute for
statistical purposes.
Statistical analysis
The normality of the data distribution was tested using
the Kolmogorov-Smirnov test. The results are expressed
as mean ± standard deviation or as median (25th to 75th
interquartile range), as appropriate. Patients were classi-
fied as hypotensive if they had a MAP ≤65 mmHg and/
or SAP <90 mmHg. Sepsis was defined according to
standard criteria [5]. As we selected an increase in CO
≥10% for defining fluid responsiveness, we chose a simi-
lar cutoff for MAP changes for defining a positive pres-
sure response. This threshold was selected assuming a
matched ventriculoarterial coupling and optimal hy-
draulic efficiency (maximal stroke work) [23]. The rela-
tionships between variables were analyzed using a linear
regression analysis. Because changes in arterial pressure
depend not only on Eadyn but also on the magnitude of
CO changes, we also calculated the weighted least-squares
regression, taking into consideration the contribution of
CO changes in the relationship between arterial pressure
increase and preinfusion Eadyn. Differences at baseline be-
tween pressure responders and non-responders were
compared by means of an independent sample t-test, and
their evolution over time was assessed by one-way analysis
of variance with repeated measurements, using group
(pressure responders vs. non-responders) as the between-subjects factor and time (preinfusion vs. postinfusion) as
the within-subjects factor. Differences between groups were
compared using an independent samples t-test. Compari-
son between preinfusion and postinfusion periods was
tested using a t-test for repeated measurements. Categorical
variables were compared using the χ2 test. For each arterial
load variable, a receiver operating characteristic (ROC)
curve was created to test the ability of predicting a positive
MAP response after VE. Areas under the ROC curve
(AUC) with 95% confidence intervals (95% CIs) were com-
pared by using the method described by DeLong et al. [24].
Optimal cutoff values were calculated by maximizing the
Youden index (J = sensitivity + specificity −1). The diagnos-
tic performance of Eadyn was also assessed on the basis of
its positive and negative likelihood ratios (LHRs). A diag-
nostic variable with potential to influence clinical decisions
is usually considered when its positive LHR is >10, its
negative LHR is <0.1 and the AUC is >0.9 [25]. A gray
zone for Eadyn cutoff was created using a resampling
method [26]. In summary, the Youden index for each
bootstrapped sample from 1,000 replications of the ori-
ginal study population was calculated, then the median
value and the 95% CI of these 1,000 optimal cut-offs were
obtained. This bootstrapped 95% CI defines a gray zone
around the optimum criterion in which formal conclu-
sions about prediction of MAP response cannot be ob-
tained [25,26].
A preliminary power analysis determined that a sample
size of 48 patients was required for detecting an AUC differ-
ence of 0.1 (α = 0.05; β= 0.20; allocation ratio = 1:1).
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analyses were two-tailed and performed using MedCalc
statistical software version 14.8.0 [27].
Results
The patients’ characteristics are summarized in Table 1. A
total of 80 VEs performed in 53 patients were studied (me-
dian, 1; interquartile range (IQR): 1 to 2; maximum: 3 per
patient). Eight VEs were excluded from the analysis because
CO did not increase by ≥10%, and one was excluded be-
cause of the presence of cardiac arrhythmia during recoding.
The hemodynamic profiles of these eight non-preloadTable 1 Characteristics and demographic dataa
Demographics Data
Age (yr) 62.7 ± 14.4
Sex (men/women) 31/22
Weight (kg) 81 ± 23
Height (cm) 167 ± 8
APACHE II score at admission 21 ± 5
Plasma lactate level at admission (mmol/L) 1.9 (1.21 to 3.12)
ICU mortality rate, n (%) 16 (30%)
Vasoactive drugs at time of inclusion
Norepinephrine, n; dose (μg kg−1 min−1) 30; 0.19 ± 0.14
Dobutamine, n; dose (μg kg−1 min−1) 13; 5 ± 2
Analgesia and sedative drugs
Fentanyl, n; dose (μg kg−1 hr−1) 28; 1.55 ± 0.57
Remifentanil, n; dose (μg kg−1 min−1) 20; 0.14 ± 0.06
Midazolam, n; dose (mg kg−1 hr−1) 32; 0.10 ± 0.04
Propofol, n; dose (mg kg−1 hr−1) 3; 1.25 (1 to 2)
Morphine, n; dose (mg kg−1 hr−1) 1; 1.8
Ventilator settings
Tidal volume (ml/kg predicted body weight) 8 (6 to 10)
Respiratory rate (breaths/min) 19 (18 to 20)
Total PEEP (cmH2O) 8 (6 to 10)
Acute circulatory failure origin, n (%)
Postoperative hypovolemia 7 (13%)
Hemorrhagic shock 4 (8%)
Anoxic encephalopathy 2 (4%)
Toxic poisoning 2 (4%)






aValues are expressed as mean ± SD, median (25th to 75th percentile) or
absolute numbers, as appropriate. APACHE II, Acute Physiology and Chronic
Health Evaluation II; ICU: intensive care unit; PEEP: positive
end-expiratory pressure.responder patients are shown in Additional file 1: Table S1.
In seven patients (13%), the arterial blood pressure was
monitored from a femoral arterial catheter. Thirty-two pa-
tients (60%) had sepsis, mainly from an abdominal source.
The patients were studied mostly during the first 24 hours
of ICU admission. The heart rate/respiratory rate ratio was
4.9 ± 0.9 at preinfusion and 4.7 ± 0.9 after VE.Hemodynamic response to volume expansion
Hemodynamic changes after VE are shown in Table 2.
Overall, VE increased CO by 14.7% (13.2% to 19.1%), SV by
20.1% (17.1% to 21.9%) and MAP by 9.8% (4.9 to 10.3%).
Thirty-three patients (41%) were classified as pressure re-
sponders. Of 32 fluid challenges performed in the 22
hypotensive patients, only 17 showed a MAP increase by
≥10% (53%). The rate of pressure responders was similar be-
tween patients with and without sepsis (34% vs. 51%;
P= 0.18), or between hypotensive and non-hypotensive pa-
tients (53% vs. 33%; P = 0.13). There was a weak relationship
between VE-induced changes in MAP and CO (R2 = 0.05;
P= 0.04) (Figure 2) and between VE-induced changes in ar-
terial pulse pressure and SV (R2 = 0.13; P <0.001).Effects of volume expansion on arterial load
Fluid administration decreased Ea from 1.75 (1.54 to
1.91) mmHg/ml to 1.59 (1.45 to 1.81) mmHg/ml (P
<0.0001) and SVR from 1,229 ± 554 dyn∙s∙cm−5 to 1,150
± 514 dyn∙s∙cm−5 (P <0.0001). Net arterial compliance
did not change. In non-responder patients, VE reduced
the static component of arterial load but did not affect
Eadyn (Table 3).
At baseline, Eadyn was higher in pressure responder pa-
tients (1.04 ± 0.28 vs. 0.60 + 0.14; P <0.0001) (Figure 3).
Pressure responders were also more hypotensive (Table 2).
Furthermore, preinfusion Eadyn and SVR were higher in
hypotensive patients (Eadyn: 0.90 ± 0.35 vs. 0.70 ± 0.23,
P <0.01; SVR: 1,036 ± 605 dyn∙s∙cm−5 vs. 1,359 ±
486 dyn∙s∙cm−5, P <0.05) (Additional file 1: Table S2). No dif-
ferences were observed in preinfusion arterial load variables
between septic and non-septic patients (Additional file 1:
Table S3).
Preinfusion Eadyn was correlated with VE-induced
changes in SAP (R2 = 0.56; P <0.0001), diastolic arterial
pressure (DAP; R2 = 0.61; P <0.0001), MAP (R2 = 0.60;
P <0.0001) and arterial pulse pressure (R2 = 0.42; P <0.0001)
(Figure 4). When adjusted for CO changes, this relationship
was higher (SAP: R2 = 0.62; DAP: R2 = 0.70; MAP: R2 =
0.69; pulse pressure: R2 = 0.44; P <0.0001, respectively;
Additional file 1: Figures S2 and S3). None of the static
components of arterial load were associated with changes
in arterial pressure produced by VE. No relationship was
observed between Eadyn and other variables of arterial load
at baseline or after VE.
Table 2 Effects of volume expansion in hemodynamic variables according to mean arterial pressure increasea
Before volume expansion After volume expansion P-valueb
CO, L/min
Responders 4.9 ± 2.2 5.8 ± 2.5c 0.581
Non-responders 5.9 ± 2.3 6.8 ± 2.6c
Heart rate, beats/min
Responders 91 ± 21 86 ± 19c 0.036
Non-responders 92 ± 17 90 ± 17c
SV, ml
Responders 56 ± 24 69 ± 26c 0.971
Non-responders 65 ± 27 77 ± 33c
CPO, W
Responders 0.7 ± 0.3d 1.0 ± 0.4c <0.001
Non-responders 0.9 ± 0.3 1.1 ± 0.4c
MAP, mmHg
Responders 67 ± 15d 80 ± 18c <0.001
Non-responders 74 ± 12 76 ± 12c
SAP, mmHg
Responders 102 ± 18d 128 ± 22c <0.001
Non-responders 113 ± 18 118 ± 20*
DAP, mmHg
Responders 51 ± 13 57 ± 14c <0.001
Non-responders 55 ± 11 55 ± 11
PP, mmHg
Responders 51 ± 17 70 ± 20c <0.001
Non-responders 58 ± 15 64 ± 17c
PPV, %
Responders 18 ± 7d 9 ± 5c <0.001
Non-responders 11 ± 5 8 ± 4c
SVV, %
Responders 17 ± 8 15 ± 7c 0.135
Non-responders 18 ± 7 15 ± 5c
aResponders are defined by a mean arterial pressure (MAP) increase ≥10%). Data are expressed as mean ± SD. bP-values refer to group (responder vs.
non-responder) and time (preinfusion vs. postinfusion) interaction using analysis of variance for repeated measurements. cP <0.05 vs. before volume expansion.
†P <0.05 vs. non-responders. CO, Cardiac output; CPO, Cardiac power output (mean arterial pressure × cardiac output/451); DAP, Diastolic arterial pressure; MAP,
Mean arterial pressure; PP, Pulse pressure (systolic pressure minus diastolic pressure); PPV, Arterial pulse pressure variation; SAP, Systolic arterial pressure; SV,
Stroke volume; SVV, Stroke volume variation.
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expansion
The AUC for preinfusion Eadyn (0.94 ± 0.03; 95% CI: 0.86
to 0.98) was higher than for any other variable of arterial
load: Ea (0.53 ± 0.07; 95% CI: 0.42 to 0.65; P <0.0001), C
(0.51 ± 0.07; 95% CI: 0.39 to 0.62; P <0.0001); SVR (0.55
± 0.07; 95% CI: 0.44 to 0.66; P <0.0001) and preinfusion
MAP (0.62 ± 0.07; 95% CI: 0.50 to 0.72; P <0.0001)
(Figure 5).
At baseline, an Eadyn value ≥0.73 predicted an increase
≥10% in MAP after VE with a sensitivity of 90.9% (95%
CI: 75.7% to 98.1%) and a specificity of 91.5% (95% CI:79.6% to 97.6%), with a positive predictive value of 88.2
(95% CI: 72.5% to 96.7%) and a negative predictive value
of 93.5 (95% CI: 82.1% to 98.6%). The positive and nega-
tive LHRs for Eadyn were 10.68 (95% CI: 4.2 to 27.4) and
0.1 (95% CI: 0.03 to 0.3), respectively. The bootstrapped
95% CI defined a gray zone for Eadyn ranging between
0.72 and 0.88. Only ten fluid challenges (12.5%) were sit-
uated in the inconclusive zone.
When only the first VE per patient was included in the
analysis, the predictive performance of Eadyn was similar
(AUC: 0.92 ± 0.04; 95% CI: 0.81 to 0.98; P = 0.64 vs. in-
cluding all fluid challenges) (Additional file 1: Figure S4).
Figure 2 Individual changes in cardiac output and mean arterial pressure after fluid administration.
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for defining a positive preload and pressure response,
the AUC of Eadyn was also excellent: 0.97 ± 0.03 (95% CI:
0.86 to 0.99; P = 0.37 vs. definition of ≥10% for CO and
MAP increases) (Additional file 1: Figure S5). Because
the impact of PPV seems to be predominant on the
Eadyn ratio, we also compared the performance of PPV
alone against Eadyn (AUC for PPV: 0.76; 95% CI: 0.65 to




Responders 1.04 ± 0.28c
Non-responders 0.60 ± 0.14
Ea, mmHg/ml
Responders 1.89 ± 0.77
Non-responders 1.82 ± 0.76
C, ml/mmHg
Responders 1.11 ± 0.36
Non-responders 1.17 ± 0.57
SVR, dyn∙s∙cm−5
Responders 1282 ± 572
Non-responders 1192 ± 545
aResponders were defined as mean arterial pressure increase ≥10% after fluid admi
(responders vs. non-responders) and time (preinfusion vs. postinfusion) interaction
non-responders. dP <0.0001 vs. before volume expansion. C, Net arterial compliance
Systemic vascular resistance.Figure S6). The ability of Eadyn for predicting pressure
responsiveness was similar between hypotensive and
non-hypotensive patients, as well as between septic and
non-septic patients (Additional file 1: Tables S4 and S5).
Discussion
In this study, we confirmed the ability of Eadyn for predicting
arterial pressure response to VE in preload-dependent pa-
tients with acute circulatory failure. The greatest strength ofarterial load variables according to mean arterial
After volume expansion P-valueb
0.62 ± 0.27d <0.001
0.59 ± 0.23
1.89 ± 0.68 <0.001
1.58 ± 0.62d
0.99 ± 0.34d <0.001
1.27 ± 0.60d
1293 ± 548 <0.001
1050 ± 469d
nistration. Data are expressed as mean ± SD. bP-values refer to group
using analysis of variance for repeated measurements. cP <0.0001 vs.
; Ea, Effective arterial elastance; Eadyn, Dynamic arterial elastance; SVR,
Figure 3 Distribution of individual values (open circles) and mean± SD (lines) of arterial load variables before fluid administration in pressure
responders. The dashed line represents the optimal cutoff for dynamic arterial elastance corresponding to maximum Youden index, and dotted lines depict
the “gray zone” calculated from bootstrapped 95% confidence interval (0.72 to 0.88). MAP-R, Mean arterial pressure responders defined by increase ≥10%;
MAP-NR, Mean arterial pressure non-responders defined by increase <10%. *P <0.0001 for MAP-R vs. MAP-NR.
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obtained from two independent signals: esophageal Doppler
monitor–derived aortic blood flow and the arterial wave-
form from a routine arterial line. So, mathematical coupling
can be excluded. Moreover, the predictive performance of
Eadyn was similar between septic and non-septic patients
and regardless of the presence of systemic hypotension.
Maintaining a constant perfusion pressure against a
variable CO is a hallmark function of an efficient cardio-
vascular system [23,28]. Arterial pressure can be consid-
ered as a complex interface between the blood ejected
by the heart, which is modulated to meet the metabolic
demands of the organism, and the arterial vascular tree,
an adaptive system influenced by its physical proprieties,
neurohormonal factors and baroreflex function [29]. Ar-
terial hypotension, therefore, is the pathological conse-
quence of loss of balance between these determinants
and often represents the first sign of an acute decom-
pensated cardiovascular system [23,28].
When hypotension occurs, fluid administration re-
mains as the first recommended therapy for restoring ar-
terial pressure in current hemodynamic resuscitation
protocols [4-6]. However, the assumption that increasing
CO will be followed by an increase to the same extent in
blood pressure is not often true [8-12], and vasopressors
are frequently introduced when an arbitrary amount of
fluids has been administered [4,5]. So, as long as no
physiological trigger for the timing of vasopressor sup-
port is established, aggressive volume resuscitation, if
aimed to a pressure target, could lead to fluid overload,delayed vasoactive therapy or even increased mortality
risk [30].
On the basis of the functional hemodynamic concept
[31], Eadyn was originally conceived to answer an emi-
nently clinical question: If a patient is fluid-responsive, will
arterial pressure improve with volume administration
[14]? Taking advantage of well-known hemodynamic ef-
fects of intermittent positive pressure ventilation on left
ventricular SV and arterial pressure [32], Eadyn depicts the
slope of the P–V curve during a respiratory cycle, allowing
the assessment of pressure responsiveness or, put another
way, defining the flow dependency of arterial pressure.
Consequently, if Eadyn is high and the patient is preload-
dependent, arterial pressure will improve along with CO
after VE. On the contrary, if Eadyn is low, even if the pa-
tient is fluid-responsive, VE will not increase blood pres-
sure and vasopressors should be considered in order to
correct hypotension. Moreover, for the same increase in
CO, the greater the preinfusion Eadyn, the greater the im-
provement in arterial pressure after VE. In our study, an
Eadyn value of 0.73 predicted pressure responsiveness with
a high sensitivity and specificity and a narrow gray zone of
uncertainty. Interestingly, this threshold is close to the
value found in our previous study [13] and similar to that
suggested in the original publication [14].
It is noteworthy that Eadyn should not be interpreted
as an actual variable of arterial load or arterial tone, but
as a functional measure of arterial load. Therefore, in
the same way that neither PPV nor SVV is an index of
cardiac preload, Eadyn should not be considered a direct
Figure 4 Linear regression analysis of the relationship between preinfusion dynamic arterial elastance (Eadyn) and changes in arterial
pressure induced by fluid administration. DAP: diastolic arterial pressure; MAP: mean arterial pressure; SAP: systolic arterial pressure; PP: arterial
pulse pressure.
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served in this study between static variables and Eadyn
supports this hypothesis.
In our previous study, we observed that none of the
static arterial load variables predicted the subsequent ar-
terial pressure response to VE [13]. Our presently re-
ported results confirm this observation in a larger group
of patients with a different methodology. Although the
lack of prediction of static variables of arterial load could
be explained by several hypotheses, one reason that mightbe argued is that our arterial load framework, although
physiologically reasonable, provides only a gross oversim-
plification of the actual nature of arterial system that ig-
nores, for example, the phenomenon of pressure wave
reflection [29]. A fuller characterization of arterial load re-
quires a frequency domain assessment using technology
outside the scope of routine hemodynamic monitoring
[15,19]. However, we think that another explanation could
be that the P–V relationship is not constant, because it
can be also affected by age, sex or pathological conditions,
Figure 5 Comparison of receiver operating characteristic curves
for testing the ability of static and dynamic arterial load variables
to detect a mean arterial pressure increase ≥10% after volume
administration. Dynamic arterial elastance (Eadyn) = area under the
receiver operating characteristic curve (AUC): 0.94 (95% CI: 0.86 to 0.98);
effective arterial elastance (Ea) = AUC: 0.53 (95% CI: 0.42 to 0.65);
systemic vascular resistance (SVR) = AUC: 0.55 (95% CI: 0.44 to 0.66);
net arterial compliance (C) = AUC: 0.51 (95% CI: 0.39 to 0.62);
preinfusion MAP = AUC: 0.62 (95% CI: 0.50 to 0.72).
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in the same patient, a single steady-state P–V relationship
could be associated to different slopes and hence different
Eadyn values.
Our study has some limitations that need to be men-
tioned. First, we decided to use the esophageal Doppler
monitor for estimating CO and SVV. This is a well-
validated method with proved benefits for guiding fluid
therapy during the perioperative period [34]. However, be-
cause this technique assumes a constant proportion of CO
through the descending aorta and a fixed aortic diameter,
changes in flow distribution to the upper part of the body
or variations in aortic diameter induced by arterial pressure
changes could potentially affect its capability to detect CO
changes [35]. Moreover, the ability of esophageal Doppler
monitoring for tracking beat-to-beat changes in SV, as may
occur during an inferior vena cava occlusion, has raised
some concerns about the accuracy of this method for calcu-
lating SVV [36,37]. More recently, two clinical studies have
demonstrated the usefulness of SVV measured by esopha-
geal Doppler monitoring for predicting fluid responsiveness
in surgical patients [38,39]. Despite these limitations, we
chose esophageal Doppler monitoring because of its abil-
ity to detect rapid hemodynamic changes and its low
dependency on arterial tone variations, unlike pulsepressure analysis-based systems [40]. Specifically, our
monitor combines the standard Doppler method with the
arterial pressure analysis, allowing the simultaneous as-
sessment of both flow and pressure, and the automatic
calculation of arterial load variables.
A second limitation is that we included preload-
dependent patients, regardless of their baseline MAP
levels. Obviously, measuring Eadyn should be considered
primarily in hypotensive patients. However, we think
that knowing whether arterial pressure will improve
with fluids could also be of interest for the clinician, be-
cause some patients could benefit from fluids adminis-
tered in order to decrease their vasopressor dosage [41].
Finally, given that a predefined level of MAP does not
guarantee an adequate perfusion pressure to all tissues
and cannot be generalized to all patients, hemodynamic
resuscitation should be targeted not only at restoring
perfusion pressure but also at providing a sufficient oxy-
gen delivery to guarantee an adequate cellular metabol-
ism [2]. However, correction of arterial hypotension
seems to be a necessary condition for normal cellular
function [1].
Conclusions
Eadyn obtained from two independent signals allowed the
prediction of arterial pressure response to fluid administra-
tion in mechanically ventilated, preload-dependent patients
with acute circulatory failure. The clinical applicability of
Eadyn seems now purely limited by technological boundaries.
Only its implementation in future hemodynamic resuscita-
tion protocols will determine the impact of Eadyn in patient
outcome.
Key messages
 Dynamic arterial elastance (Eadyn), defined as the
ratio between pulse pressure variation (PPV) and
stroke volume variation (SVV), measured from two
independent signals, predicted the arterial pressure
response to fluid administration in mechanically
ventilated, preload-dependent patients.
 An Eadyn value ≥0.73 predicted a mean arterial pressure
increase ≥10% after volume expansion with 90.9%
sensitivity and 91.5% specificity, as well as a narrow gray
zone ranging between 0.72 and 0.88. The predictive
performance of Eadyn was similar in septic and non-
septic patients and regardless of the presence of sys-
temic hypotension.
 The arterial pressure response to volume administration
was not related to static arterial load variables.
 Preload-dependent patients in whom arterial
pressure did not increase after volume expansion
showed a decrease in the static component of
arterial load.
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